Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELAN Elanco Animal Health	$23.61 -4.4%	$22.88	$13.15 ▼ $27.72	$11.80B	1.69	7.07 million shs	4.21 million shs
IDXX IDEXX Laboratories	$562.16 -0.5%	$563.05	$506.91 ▼ $769.98	$44.34B	1.55	635,392 shs	459,089 shs
LLY Eli Lilly and Company	$1,133.15 +0.7%	$974.59	$623.78 ▼ $1,166.29	$1.07T	0.53	2.99 million shs	4.12 million shs
PAWZ ProShares Pet Care ETF	$47.27 -0.3%	$50.03	$45.96 ▼ $59.85	$51.05M	1.16	4,376 shs	1,871 shs
PFE Pfizer	$26.04 +1.4%	$26.62	$23.11 ▼ $28.75	$148.41B	0.34	31.71 million shs	31.84 million shs
ZTS Zoetis	$79.49 0.0%	$100.52	$72.38 ▼ $171.52	$33.30B	0.75	8.96 million shs	5.29 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELAN Elanco Animal Health	-4.37%	-1.04%	-9.91%	+0.99%	+75.42%
IDXX IDEXX Laboratories	-0.46%	-0.24%	-2.95%	-7.60%	+7.11%
LLY Eli Lilly and Company	+0.72%	+2.51%	+14.75%	+14.39%	+47.78%
PAWZ ProShares Pet Care ETF	-0.25%	-1.58%	-7.20%	-12.69%	-21.09%
PFE Pfizer	+1.34%	-0.53%	-1.76%	-3.79%	+11.20%
ZTS Zoetis	-0.12%	+2.16%	-28.74%	-34.60%	-52.87%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELAN Elanco Animal Health	$23.61 -4.4%	$22.88	$13.15 ▼ $27.72	$11.80B	1.69	7.07 million shs	4.21 million shs
IDXX IDEXX Laboratories	$562.16 -0.5%	$563.05	$506.91 ▼ $769.98	$44.34B	1.55	635,392 shs	459,089 shs
LLY Eli Lilly and Company	$1,133.15 +0.7%	$974.59	$623.78 ▼ $1,166.29	$1.07T	0.53	2.99 million shs	4.12 million shs
PAWZ ProShares Pet Care ETF	$47.27 -0.3%	$50.03	$45.96 ▼ $59.85	$51.05M	1.16	4,376 shs	1,871 shs
PFE Pfizer	$26.04 +1.4%	$26.62	$23.11 ▼ $28.75	$148.41B	0.34	31.71 million shs	31.84 million shs
ZTS Zoetis	$79.49 0.0%	$100.52	$72.38 ▼ $171.52	$33.30B	0.75	8.96 million shs	5.29 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELAN Elanco Animal Health	-4.37%	-1.04%	-9.91%	+0.99%	+75.42%
IDXX IDEXX Laboratories	-0.46%	-0.24%	-2.95%	-7.60%	+7.11%
LLY Eli Lilly and Company	+0.72%	+2.51%	+14.75%	+14.39%	+47.78%
PAWZ ProShares Pet Care ETF	-0.25%	-1.58%	-7.20%	-12.69%	-21.09%
PFE Pfizer	+1.34%	-0.53%	-1.76%	-3.79%	+11.20%
ZTS Zoetis	-0.12%	+2.16%	-28.74%	-34.60%	-52.87%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ELAN Elanco Animal Health	2.77	Moderate Buy	$28.20	19.44% Upside
IDXX IDEXX Laboratories	2.64	Moderate Buy	$751.00	33.59% Upside
LLY Eli Lilly and Company	2.87	Moderate Buy	$1,227.00	8.28% Upside
PAWZ ProShares Pet Care ETF	2.58	Moderate Buy	$47.27	N/A
PFE Pfizer	2.20	Hold	$28.82	10.68% Upside
ZTS Zoetis	2.33	Hold	$133.92	68.46% Upside

Current Analyst Ratings Breakdown

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/5/2026	LLY Eli Lilly and Company	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
6/1/2026	PFE Pfizer	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
5/27/2026	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$27.00
5/27/2026	ZTS Zoetis	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
5/26/2026	LLY Eli Lilly and Company	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$1,133.00 ➝ $1,251.00
5/26/2026	LLY Eli Lilly and Company	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1,119.00
5/22/2026	ZTS Zoetis	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$105.00 ➝ $95.00
5/22/2026	LLY Eli Lilly and Company	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$1,283.00
5/21/2026	LLY Eli Lilly and Company	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$1,350.00
5/21/2026	LLY Eli Lilly and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
5/21/2026	LLY Eli Lilly and Company	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target		$1,300.00 ➝ $1,330.00

(Data available from 6/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ELAN Elanco Animal Health	$4.72B	2.50	$2.32 per share	10.18	$13.18 per share	1.79
IDXX IDEXX Laboratories	$4.30B	10.30	$15.09 per share	37.26	$20.10 per share	27.97
LLY Eli Lilly and Company	$65.18B	16.37	$25.18 per share	45.01	$28.07 per share	40.37
PAWZ ProShares Pet Care ETF	N/A	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$62.58B	2.37	$4.40 per share	5.92	$15.26 per share	1.71
ZTS Zoetis	$9.47B	3.52	$7.57 per share	10.50	$7.56 per share	10.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ELAN Elanco Animal Health	-$232M	-$0.50	N/A	19.35	1.55	-4.95%	7.42%	3.66%	8/6/2026 (Estimated)
IDXX IDEXX Laboratories	$1.06B	$13.58	41.40	34.01	3.08	24.63%	70.87%	32.56%	8/3/2026 (Estimated)
LLY Eli Lilly and Company	$20.64B	$28.15	40.25	25.43	1.24	34.98%	105.77%	23.76%	8/5/2026 (Estimated)
PAWZ ProShares Pet Care ETF	N/A	N/A	23.65	N/A	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$7.77B	$1.31	19.88	9.11	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)
ZTS Zoetis	$2.67B	$6.03	13.18	10.77	1.24	27.80%	66.85%	18.79%	8/4/2026 (Estimated)

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2026	Q1 2026	ZTS Zoetis	$1.60	$1.53	-$0.07	$1.42	$2.30 billion	$2.26 billion
5/6/2026	Q1 2026	ELAN Elanco Animal Health	$0.34	$0.40	+$0.06	$0.11	$1.28 billion	$1.37 billion
5/5/2026	Q1 2026	IDXX IDEXX Laboratories	$3.41	$3.47	+$0.06	$3.47	$1.12 billion	$1.14 billion
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/30/2026	Q1 2026	LLY Eli Lilly and Company	$6.97	$8.55	+$1.58	$8.26	$17.82 billion	$19.80 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ELAN Elanco Animal Health	N/A	N/A	N/A	N/A	N/A
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.92	0.61%	+15.18%	24.58%	11 Years
PAWZ ProShares Pet Care ETF	$0.42	0.89%	N/A	N/A	N/A
PFE Pfizer	$1.72	6.60%	-13.20%	131.30%	16 Years
ZTS Zoetis	$2.12	2.67%	+20.11%	35.16%	14 Years

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/20/2026	ZTS Zoetis	quarterly	$0.53	2.66%	7/20/2026	7/20/2026	9/1/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026
5/4/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.69%	5/15/2026	5/15/2026	6/10/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ELAN Elanco Animal Health	0.60	2.16	1.12
IDXX IDEXX Laboratories	0.19	1.12	0.82
LLY Eli Lilly and Company	1.26	1.50	1.10
PAWZ ProShares Pet Care ETF	N/A	N/A	N/A
PFE Pfizer	0.67	1.25	0.94
ZTS Zoetis	2.80	3.15	1.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ELAN Elanco Animal Health	97.48%
IDXX IDEXX Laboratories	87.84%
LLY Eli Lilly and Company	82.53%
PAWZ ProShares Pet Care ETF	N/A
PFE Pfizer	68.36%
ZTS Zoetis	92.80%

Insider Ownership

Company	Insider Ownership
ELAN Elanco Animal Health	1.14%
IDXX IDEXX Laboratories	0.79%
LLY Eli Lilly and Company	0.14%
PAWZ ProShares Pet Care ETF	N/A
PFE Pfizer	0.62%
ZTS Zoetis	0.22%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ELAN Elanco Animal Health	9,400	499.45 million	493.76 million	Optionable
IDXX IDEXX Laboratories	11,000	78.88 million	78.26 million	Optionable
LLY Eli Lilly and Company	50,000	941.74 million	940.42 million	Optionable
PAWZ ProShares Pet Care ETF	N/A	1.08 million	N/A	Not Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable
ZTS Zoetis	14,500	419.23 million	418.31 million	Optionable

ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Headlines

Recent News About These Companies

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

June 6 at 10:30 AM | prnewswire.com

Highbridge Capital Management LLC Acquires New Shares in Zoetis Inc. $ZTS

June 6 at 6:09 AM | marketbeat.com

Natixis Advisors LLC Lowers Position in Zoetis Inc. $ZTS

June 6 at 5:18 AM | marketbeat.com

Cibc World Market Inc. Decreases Stock Position in Zoetis Inc. $ZTS

June 6 at 4:08 AM | marketbeat.com

BI Asset Management Fondsmaeglerselskab A S Sells 101,963 Shares of Zoetis Inc. $ZTS

June 6 at 3:36 AM | marketbeat.com

Jim Cramer Recommends Elanco Over Zoetis

June 5 at 11:11 AM | insidermonkey.com

Jim Cramer Recommends Elanco Over Zoetis

June 5 at 10:50 AM | finance.yahoo.com

ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

June 5 at 10:05 AM | globenewswire.com

ZTS Deadline Alert: The Gross Law Firm Reminds Zoetis Inc. (ZTS) Investors of Securities Class Action Deadline on July 27, 2026

June 5 at 9:00 AM | globenewswire.com

TD Asset Management Inc Has $196.78 Million Position in Zoetis Inc. $ZTS

June 5 at 5:56 AM | marketbeat.com

Clifford Swan Investment Counsel LLC Purchases 45,040 Shares of Zoetis Inc. $ZTS

June 5 at 4:38 AM | marketbeat.com

A Look At Zoetis (ZTS) Valuation After Guidance Cut Legal Actions And Companion Animal Headwinds

June 4 at 12:56 AM | finance.yahoo.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

June 4 at 11:41 PM | newsfilecorp.comN

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before ...

June 4 at 7:56 PM | gazettextra.comG

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

June 4 at 6:48 PM | globenewswire.com

ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

June 4 at 5:33 PM | prnewswire.com

How Is Zoetis’ Stock Performance Compared to Other Healthcare Stocks?

June 4 at 4:50 PM | finance.yahoo.com

Kaplan Fox Alerts Zoetis Inc. (NYSE: ZTS) Investors to a Securities Class Action Lawsuit - Deadline is July 27, 2026

June 4 at 2:55 PM | theglobeandmail.com

Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

June 4 at 2:55 PM | tmcnet.com

Confirmed screwworm case in Texas sends two biotech stocks higher

June 4 at 12:57 PM | cnbc.com

Zoetis Sees Unusually High Options Volume (NYSE:ZTS)

June 4 at 12:14 PM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Company Descriptions

Elanco Animal Health NYSE:ELAN

$23.61 -1.10 (-4.45%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$23.62 +0.01 (+0.06%)

As of 06/5/2026 07:05 PM Eastern

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

IDEXX Laboratories NASDAQ:IDXX

$562.16 -2.58 (-0.46%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$558.14 -4.01 (-0.71%)

As of 06/5/2026 07:21 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Eli Lilly and Company NYSE:LLY

$1,133.14 +7.88 (+0.70%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$1,125.00 -8.14 (-0.72%)

As of 06/5/2026 08:00 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

ProShares Pet Care ETF BATS:PAWZ

$47.27 -0.12 (-0.25%)

As of 06/5/2026 04:10 PM Eastern

The ProShares Pet Care ETF (PAWZ) is an exchange-traded fund that is based on the FactSet Pet Care index. The fund tracks a tier-weighted index of global equities related to pet ownership. PAWZ was launched on Nov 5, 2018 and is managed by ProShares.

Pfizer NYSE:PFE

$26.04 +0.35 (+1.37%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$25.97 -0.08 (-0.29%)

As of 06/5/2026 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Zoetis NYSE:ZTS

$79.49 -0.03 (-0.03%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$78.76 -0.73 (-0.92%)

As of 06/5/2026 07:54 PM Eastern

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Earnings

Compare Dividends

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Company Descriptions

Elanco Animal Health NYSE:ELAN

IDEXX Laboratories NASDAQ:IDXX

Eli Lilly and Company NYSE:LLY

ProShares Pet Care ETF BATS:PAWZ

Pfizer NYSE:PFE

Zoetis NYSE:ZTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools